TORONTO , and GLIL YAM, Israel , Feb. 16, 2023 /CNW/ -- IM Cannabis Corp. (the " Company " or " IMC ") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce that it has closed a fifth and final tranche of its previously announced non-brokered private placement offering of units of the Company (each a " Unit ") pursuant to the listed issuer financing exemption under Part 5A of National... Read More

TORONTO and GLIL YAM, Israel , Jan. 27, 2023 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company announces that it has engaged certain eligible finders (each a " Finder "), in connection with its previously announced private placement offering of units of the Company (each, a " Unit ") pursuant to the listed issuer financing exemption under Part 5A of... Read More

TORONTO and GLIL YAM, Israel , Jan. 13, 2023 /CNW/ - IM Cannabis Corp. (the " Company " or " IMC ") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce a non-brokered private placement of a minimum of 400,000 units and a maximum of 2,960,000 units of the Company (each a " Unit ") at a price of US$1 .25 per Unit for aggregate gross proceeds of a minimum of US$500,000 and a maximum of... Read More

Marc Lustig , Executive Chairman of the Company Subscribes for 1,112,504 common shares at USD$0.50 IM Cannabis Corp. (" IM Cannabis " or the " Company ") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , is pleased to announce that it has closed the second tranche of its non-brokered private placement, as described in its press release... Read More

Rafael Gabay, a promoter and significant shareholder of IM Cannabis Corp. (" IMCC " or the " Company ") (CSE: IMCC) (NASDAQ: IMCC), announces that he has acquired an aggregate of 613,496 common shares in the capital of IMCC (the " Common Shares ") as part of IMCC's non-brokered private placement of 4,887,496 Common Shares at a price of USD$0.50 per Common Share for aggregate proceeds of USD$2,443,748 (the " Private Placement... Read More

IM Cannabis Corp. (" IM Cannabis " or the " Company ") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , is pleased to announce that it has closed the first tranche of its non-brokered private placement, as described in its press release of August 19, 2022 (the " Offering ") of 4,887,496 common shares of the Company (each a " Common... Read More

IM Cannabis Corp. (" IM Cannabis " or the " Company ") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , is pleased to announce that it is undertaking a non-brokered private placement for aggregate gross proceeds of up to USD$5,000,000 (the " Offering "). The Offering, which is expected to close in one or more tranches, will be led by... Read More

Gross margin of 24%, which is expected to increase with further asset integration, product availability, and operational improvements Approximately $6.5 million per year in expected cash cost savings from streamlining operations in Canada and closure of Israeli cultivation farm IM Cannabis Corp . (the " Company ", " IM Cannabis ", or " IMC ") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis... Read More

Dramatically expands IP portfolio of cannabinoid synthesis related genes and enzymes Tackles known enzymatic and modification bottlenecks and challenges in biosynthesis Xinteza API Ltd ., an innovative biosynthesis technology company, announced today that it has expanded its IP portfolio with a breakthrough discovery of a novel, non-cannabis plant-derived production system, which is capable of highly efficient and flawless... Read More

IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , will report operational and financial results for the second quarter ended June 30, 2022 , on Monday, August 15, 2022 before market opens. The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the... Read More

IM Cannabis Corp . (CSE: IMCC) (NASDAQ: IMCC) (the " Company ", " IM Cannabis ", or " IMC "), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , today announced that the Company received written notification (the " Notification Letter ") from The Nasdaq Stock Market LLC (" Nasdaq ") on July 13, 2022 , that the Company is not in compliance with the minimum bid... Read More

Gross Profit Increased 37% from Q1 2021 as Operational Efficiencies from Integration Take Hold; Company Expects to Achieve Positive Adjusted EBITDA in Q2 2022 IM Cannabis Corp. (the " Company ", " IM Cannabis ", or " IMC ") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , provided financial results for the three months ended March 31,... Read More

IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , will report operational and financial results for the first quarter ended March 31, 2022 after market close on Thursday, May 12, 2022 . Management will host a conference call to discuss the results, followed by a... Read More

Oren Shuster, CEO, director and founder of IM Cannabis Corp. (" IMCC " or the " Company ") (CSE: IMCC) (NASDAQ: IMCC), announces that he has acquired an aggregate of 150,000 common shares in the capital of IMCC (the " Common Shares ") in a series of open market transactions between April 5 and 8, 2022 through the facilities of the Nasdaq Capital Market (the " NASDAQ ") (the " Acquisition "). Mr. Shuster acquired the Common... Read More

Closure of Sde Avraham farm in Israel optimizes Company's organizational structure by fully leveraging global import-export supply chain Increase in Revolving Credit Facility availability to $15 million supports increased global demand for premium cannabis IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel... Read More

Fiscal Year 2021 revenues increased 242% year-over-year to a record of over $54 million Q4 2021 revenues increased 309% year-over-year and 39% compared to Q3 2021 Sequential revenue growth and gross margin improvement expected in Q1 2022 IM Cannabis Corp . (the " Company ", " IM Cannabis ", or "IMC" ) (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada... Read More

Transaction expands IMC's footprint into Israel's largest city while positioning the Company as one of the largest retailers of medical cannabis in the country IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , has completed the strategic acquisition of 51% of the rights in Oranim... Read More

IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE: IMCC, NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , has rescheduled the release of its operational and financial results for the fourth quarter and full year ended December 31, 2021 , to before market open on Thursday, March 31, 2022 . Management will host a conference call to... Read More

IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE: IMCC, NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , will report operational and financial results for the fourth quarter and full year ended December 31, 2021 before market open on Wednesday, March 30, 2022 . Management will host a conference call to discuss the results, followed by... Read More

IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel , Canada , and Germany , has completed three strategic acquisitions announced in 2021. The acquisitions were completed through IMC Holdings Ltd. (" IMC Holdings "), a wholly-owned subsidiary of IM Cannabis Corp. and I.M.C Pharma Ltd. (" IMC Pharma "), IMC... Read More

The successful import demonstrates the strength of the IM Cannabis global supply chain and business model IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE:IMCC) (NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany is pleased to announce that Focus Medical Herbs Ltd. (" Focus Medical ") has completed the importation of approximately 399... Read More

Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp. IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE:IMCC) (NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany today announced the appointment of... Read More

IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE:IMCC, NASDAQ:IMCC), a global cannabis company with operations in Israel, Canada, and Germany is pleased to announce plans to launch its popular Canadian WAGNERS brand in the German medical cannabis market in 2022 and begin exports of... Read More

Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million Oranim's trailing 12-month revenue approximately $16.5 million and gross margin approximately 25%[1] before recognizing synergies IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE:IMCC), (NASDAQ:IMCC), a leading medical and adult-use recreational... Read More

IM Cannabis' popular recreational cannabis brand WAGNERS will be available in Israel in 2022, enhancing IM Cannabis' presence in the market IM Cannabis Corp . (the " Company " or " IM Cannabis ") (CSE:IMCC) (NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany is pleased to announce that on November 28, 2021, Focus Medical Herbs Ltd. (" Focus Medical ")... Read More

IM Cannabis Corp . (the "Company" or "IM Cannabis") (CSE:IMCC) (NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the fourth installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading centre with an IMC-GDP license from Panaxia Pharmaceutical Industries Israel Ltd.... Read More

Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022 Canadian recreational brands WAGNERS and Highland Grow continue to gain market share, with sales in Ontario from June to October increasing by over 110% IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (" MCO ") in... Read More

IM Cannabis Corp . (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the third installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading center with an IMC-GDP license from Panaxia Pharmaceutical Industries Israel Ltd.... Read More

IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, provides details of the shares issued as part of the share consideration paid in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading center IMC-GDP license... Read More

Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021 Acquisition of Vironna pharmacy positions IMC in rapidly growing Arab consumer segment in Israel Following strong start to Q3 across each of its geographic segments, IMC expects significant revenue growth this quarter TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 16, 2021 / IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC), (NASDAQ:IMCC), a... Read More

IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the signing of a binding letter of intent (the " Binding LOI ") with cbdMD, Inc. ( YCBD, YCBDpA) , one of the leading and most highly trusted and recognized CBD health & wellness companies.... Read More

IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the voting results from its annual general and special meeting of shareholders held on Wednesday July 28, 2021 (the " Meeting "). A total of 37,108,584 common shares of the Company were voted... Read More

Strategically located, best in class retailer with approximately CAD$8 million in annualized revenue Purchase price of CAD$4.6 million IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the acquisition of the outstanding ordinary shares of R.A.... Read More

IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces the completion of a new, state-of-the-art logistics centre in Germany (the "Logistics Centre") that will allow Adjupharm GmbH ("Adjupharm"), the Company's fully licensed EU-GMP subsidiary, to internally manage... Read More

IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCo German Brand Institute awards IMC with the "German Brand Award 2021" for the Company's successful market launch campaign Israeli Ministerial Committee on Legislative Affairs approves bill for legalization of CBD and decriminalization of cannabis consumers on July 11th IM... Read More

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, and MYM Nutraceuticals Inc. ("MYM"), a Canadian cultivator, processor, and distributor of premium cannabis, are pleased to announce, further to IMC's press release on July 6, 2021, the closing of IMC's acquisition of MYM... Read More

Highland Grow is currently profitable on an EBITDA basis, unlocks margin expansion and is expected to be immediately accretive to IM Cannabis Super premium positioning, complementary brands, enhanced distribution and export opportunities provide compelling strategic rationale Closing is expected on or around July 9, 2021 IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a multi-country operator ("MCO") in... Read More

Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC Over 90% of committed and tallied common shares are being voted in favor of the Transaction IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, is pleased to... Read More

Conditions Evaluated Include Oncology, PTSD, Rheumatoid Arthritis, Chronic Pain, Insomnia, Back Pain and Inflammatory Bowel Diseases Conducted by Leading Contract Research Organization for Cannabis Research, Survey Covered More Than 650 Patients Using FDA-Validated Questionnaires IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational... Read More

IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical") has signed a multi-year supply agreement with The Flowr Corporation ("Flowr") (TSX.V:FLWR, OTC:FLWPF), a Canadian licensed producer of ultra-premium... Read More

Launches WAGNERS brand with new cultivars and SKUs MYM shareholder meeting set for July 5, 2021 Substantially completes loan portfolio run-off and realizes a 24% IRR IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to provide the following update. F... Read More

Q1 2021 revenues of $8.8 million, an 80% sequential increase from Q4 2020 with Gross margin of 53% Strong sequential growth expected to continue with focus on further expanding premium product portfolio in Israel, contracted shipments into German market and inclusion of full quarter of Canadian sales following successful integration of Trichome IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC, NASDAQ:IMCC), a... Read More

IM Cannabis Corp. (" IMC " or the " Company ") (CSE: IMCC), (NASDAQ: IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the closing of its previously announced overnight marketed offering (the " Offering ") of 6,086,956 common shares of the Company (each an " Offered Share ") at a price of US$5.75 per... Read More

IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that is has entered into a best-efforts agency agreement (the " Agency Agreement ") in connection with its previously announced overnight marketed offering (the " Offering ") of common shares of the... Read More

IM Cannabis Corp. (" IMC " or the " Company ") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that it has commenced an overnight marketed offering (the " Offering ") of the Company's common shares (each an " Offered Share ") on a best-efforts agency basis. The Company may also issue to purchasers... Read More

With Israel 's Fast-Paced E-Commerce Adoption and Cannabis Market's High Growth Rate (Averaging 4 Percent 1 per Month), Panaxia's Online Platform to Support Patient Base Expansion Acquisition Broadens IMC's Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand Awareness Offers Additional Opportunity to Generate Revenue and Margin on Third-Party Products... Read More

Q4 2020: revenues of $4.9 million and gross margin of 57% 1 ; FY 2020: revenues of $15.9 million and gross margin of 55% 1 . Preliminary unaudited Q1 2021 revenues expected to be in the range of $8.5 - $9.0 million; gross margin expected to be in the range of 50% to 55%. Q2 2021 revenues expected to be in the range of $17 million - $19 million from continued growth in Israel, resumption of product shipments and growth of... Read More

Total voting support agreements for the Transaction now represent 44.4%, or 162.7 million, of the total votes outstanding including all senior management and board members Shareholders to benefit from a global platform of premium and super premium brands and distribution through Canada, Israel and Europe The Transaction has been approved by an MYM Special Committee of Independent Directors MYM Nutraceuticals Inc. (CSE: MYM)... Read More

TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, announced that its subsidiary, Adjupharm GmbH ("Adjupharm"), recently signed a supply agreement (the "Supply Agreement") with... Read More

IMC Subsidiary, Adjupharm, Signs New Supply Agreement to Expand Product Portfolio Agreement with Northern Green Canada Strengthens Adjupharm's Position as Leading EU GMP-Certified Medical Cannabis Distributor in Europe IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany,... Read More

Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMC Highland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively[1] Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergies MYM shareholders will receive 0.022 IMC shares for each MYM share,... Read More

IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC) ( NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that it has filed a final short form base shelf prospectus (the " Shelf Prospectus ") with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada and... Read More

IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the closing of its acquisition of Trichome Financial Corp. (" Trichome "), previously announced on December 30, 2020 (the " Transaction "). The Transaction was completed pursuant a plan of arrangement under the... Read More

IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel and Germany, has filed a preliminary short form base shelf prospectus (the " Shelf Prospectus ") with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada, and will file a corresponding shelf... Read More

Multi-year agreement enables IMC to launch a premium product category in Israel - one of the world's largest import markets for medical cannabis The agreement adds another international partnership to IMC's supply network IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that... Read More